Navigation Links
Chorea in Medical News

XENAZINE(R) (Tetrabenazine) Approved by FDA for Patients with Chorea Associated with Huntington's Disease

... XENAZINE(R) (tetrabenazine) for the treatment of chorea associated with Huntington's disease (HD). ... that XENAZINE significantly reduced patients' chorea burden, improved global outcome scores, and was ... changes and is ultimately a fatal condition. chorea is the most common symptom, affecting ...

FDA Advisory Committee Votes Unanimously to Recommend Approval of Tetrabenazine for Chorea Associated With Huntington Disease

... first drug approved in the United States to treat chorea associated with Huntington disease (HD). "The ... changes, that is ultimately a fatal condition. chorea is characterized by excessive, involuntary and ... to the patients for whom we care." chorea affects over 30,000 Americans, interfering with ...

The First Treatment Specifically Approved for Huntington's Disease Patients is Now Available in the United States

... U.S. Food and Drug Administration (FDA) approved drug for the treatment of chorea associated with Huntington's Disease (HD), is now available in the United ... chorea, a symptom present in an estimated 90 percent of people with HD. chorea is a debilitating movement disorder characterized by excessive, ...

Statement on FDA's Approval of XENAZINE(R) for the Treatment of Chorea Associated With Huntington's Disease

... has approved Xenazine, or tetrabenazine, for the treatment of chorea associated with Huntington's disease. "Chorea is a major cause of disability and death in patients with Huntington's disease. chorea is not just a mere inconvenience; it can prevent Huntington's disease ...

Frost & Sullivan Lauds OVATION Pharmaceuticals for Its Business Model and Ability to Sustain Growth

... owned subsidiary of Biovail Corp., marked the approval of the first-and-only medication available in the U.S. approved specifically for treating chorea associated with Huntington's disease (HD), a rare neurodegenerative disease affecting fewer than 25,000 Americans. From OVATION's prolific ...

S&R Communications Group Partners With Ovation Pharmaceuticals to Launch Xenazine* (tetrabenazine)

... Communications Group has entered a strategic partnership with Ovation Pharmaceuticals, Inc., to launch Xenazine* (tetrabenazine), a treatment for chorea associated with Huntington's disease (HD). Xenazine is the first and only FDA-approved treatment specifically developed for any HD-related symptom. ...

HDSA Applauds Announcement of the First Therapy to be Approved for the Specific Treatment of a Symptom of Huntington's Disease

... NEW YORK, Aug. 15 /PRNewswire/ -- The approval of Xenazine(R) (tetrabenazine), for the treatment of chorea associated with Huntington's Disease (HD), the first therapy to be approved specifically for the disease, is a significant milestone for all of our ...

FDA approves first drug for Huntington's disease

... in Europe, Canada and Australia to treat one of the most disabling symptoms of Huntington's disease, involuntary writhing movements known as chorea. chorea is one of the trademark symptoms of the disease, which directly affects about 30,000 people in the United States today; another 70,000 people who are ...

Alcohol Dehydrogenase Gene may Protect from Developing Alcoholism

... at high genetic risk for alcoholism can choose not to drink. There are no genes for alcohol dependence like there are genes for Huntington's chorea or other single-gene disorders. There are only genes that influence risk and protection for the disorder. While there have been a number of studies ...
Chorea in Medical Technology

Clinical Trial Results Suggest Long-Term Treatment Benefit of Tetrabenazine for Chorea Associated with Huntington's Disease

... can be used successfully to sustain reduced chorea burden in long-term use. "These findings ... effects, we were able to maintain reduced chorea burden." Tetrabenazine is designed to ... involved in abnormal movements such as chorea. chorea can be a debilitating feature of a number ...
Chorea in Medical Dictionary

Athetosis

... responsible for smooth muscular movement . chorea Involuntary, rapid, jerky movement s. Tics , spasm , athetosis (slow, writhing motions), chorea (rapid, randomly irregular jerky movement s) ... hepatic encephalopathy , and Huntington's chorea . Choosing a Primary Care Provider Choosing ...

Chorea

... chorea Related Category: Pathology (kr´, k-) or ... movement s of the face and extremities. chorea refers to rapid complex body movement s that ... and purposeful but are, in fact, involuntary. chorea was thought suggestive of a grotesque dance. ...

Rheumatic fever

... appear in several different forms. Sydenham's chorea is one of five "major criteria" for the ... This germ also causes strep throat . Sydenham chorea is a disorder that occurs weeks after the body ... prevent the subsequent development of Sydenham's chorea . Sometimes, however, the symptoms of strep ...

Chloasma

... Patellae (CMP) (Runner's Knee ) Chondromalacia Patellae chorea Minor (Sydenham's chorea ) Choriocarcinoma ... ...

Cholera

... Patellae (CMP) (Runner's Knee ) Chondromalacia Patellae chorea Minor (Sydenham's chorea ) Choriocarcinoma Christmas Disease ( Hemophilia B ) ... ...

Cholelithiasis

... Patellae (CMP) (Runner's Knee ) Chondromalacia Patellae chorea Minor (Sydenham's chorea ) Choriocarcinoma Christmas Disease ( Hemophilia B ) ... ...

Cholecystitis

... Patellae (CMP) (Runner's Knee ) Chondromalacia Patellae chorea Minor (Sydenham's chorea ) Choriocarcinoma ... Cholecystitis Choledocholithiasis (see ...

Gallstones

... Patellae (CMP) (Runner's Knee ) Chondromalacia Patellae chorea Minor (Sydenham's chorea ) Choriocarcinoma Christmas Disease ( Hemophilia B ) ... ...

Gallstone

... Patellae (CMP) (Runner's Knee ) Chondromalacia Patellae chorea Minor (Sydenham's chorea ) Choriocarcinoma Christmas Disease ( Hemophilia B ) ... ...

Melasma

... Patellae (CMP) (Runner's Knee ) Chondromalacia Patellae chorea Minor (Sydenham's chorea ) Choriocarcinoma ... ...

More>>

Chorea in Biological Technology

Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer

... product candidate, tetrabenazine, a highly selective and reversible dopamine depletor in Phase 3 clinical trials for potential use as a treatment for chorea associated with Huntington's Disease. He joins Prestwick most recently from Zelos Therapeutics, where he was Executive Vice President of Development ...

Angel groups in Chicagoland beginning to sprout

... and spent a good portion of his life there. He finally died at age 55 on Oct. 3, 1967 at Creedmore State Hospital in Queens, N.Y. of Huntingtons chorea (a debilitative disease he had been diagnosed with 13 years earlier). Early in his career, Bob Dylan traveled to New York City from his native ...
Other Contents
(Date:3/4/2015)... (PRWEB) March 04, 2015 Starting February ... LASIK and PRK procedures at their new location in ... Dr. Joseph King and Dr. Gabriel Chu also provide ... in Surrey is named Fraser Valley Cataract and Laser ... accredited by the College of Physicians and Surgeons of ...
(Date:3/4/2015)... Alliance Healthcare Foundation (AHF), a non-profit organization working ... in San Diego and Imperial Counties, announced today that ... Grants program with awards totaling $1 million. , ... Support Grants program. Grant recipients were chosen through a ... committee, as well as the community as a whole. ...
(Date:3/4/2015)... " Optrix by Body Glove ” ... Tech Report, which takes a look at the latest ... Scott Steinberg, a special reporter for NewsWatch and a ... viewers how they have an ultra-rugged, waterproof case with ... a major player at the Consumer Electronics Show in ...
(Date:3/4/2015)... As seen on Advanced Fertility Center ... a painful condition in which the lining of the ... leading to very unpleasant symptoms and complications that greatly ... terrible effect on women’s quality of life due to ... cause of infertility in women and carries a huge ...
(Date:3/4/2015)... 04, 2015 The New Mel Brooks ... music, will be performed by the award-winning Drama Department ... this March 6-22, 2015, on Fridays, Saturdays and Sundays. ... High School (27118 Silver Spur Road, Rolling Hills ... the program or may be purchased on-line at ...
Breaking Medicine News(10 mins):Health News:King LASIK relocates to Surrey, British Columbia 2Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 2Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 3Health News:A Waterproof Phone Case with an Interchangeable Lens System was Featured on NewsWatch Television on January 30, 2015 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 3Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2
(Date:1/22/2015)... MELBOURNE, Fla. , Jan. 13, 2015  Today, ... wearable technology, launched its crowdfunding campaign on Fundable, ... accelerate the build of production capacity to meet ... Photo - http://photos.prnewswire.com/prnh/20150113/168790 ...
(Date:1/22/2015)... man-made form of insulin delivered by nasal spray may ... with mild cognitive impairment and Alzheimer,s disease dementia, according ... Forest Baptist Medical Center. The study,s subjects ... (MCI) or mild to moderate Alzheimer,s dementia (AD). Those ...
(Date:1/22/2015)... YORK , Jan. 21, 2015  Analyst Report Issued by ... Card Brands report showed that planet-wide, transactions at merchants on ... while the total number of credit, debit, and prepaid cards ... U.S. were victims of fraudulent card usage in 2012, and ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
Other TagsOther Tags